-
MIL@b is an interdisciplinary research group. Scientist at MIL@b pull together all necessary backgrounds to conduct frontier research in Metabolomics (engineers, computer scientist, chemists, physicists, biochemists, etc). Our group capitalizes on metabolomics expertise at all levels.
-
MIL@b scientific focus is twofold: developing cutting-edge technologies to turn metabolomics into a functional genomics tool and deploying such technologies to advance the study of non-communicable multigenic and multifactorial diseases such as cancer and diabetes.
-
MIL@b research activities focus in applying engineering and technology principles to understand metabolism from a systems perspective, thus helping to move forward precision and personalized medicine. These activities are vertebrated across the following research lines:
-
1) Computational metabolomics
-
2) Label-free molecular histology
-
3) Clinical metabolomics
-
-
MIL@b has a marked translational character. In one hand, scientist at MIL@b operate the Metabolomics Platform, a CIBERDEM-URV joint research facility created in 2007 and offering advanced metabolomics services to scientific and medical community. On the other hand, MIL@b offers in-house developed computational tools to the research community. An important transfer activity is to offer these tools as fee-for-service and pay as you go DATOMA CLOUD PLATFORM (https://datoma.cloud/)
-
MIL@b scientist have played pivotal roles in bringing metabolomics to the forefront of official academic programmes, leading on the creation of the Spanish Metabolomics Network (MetaboRed, RED2018-102457-T) and the Spanish Metabolomics Society (SESMet), where Dr. O.Yanes is acting as the official chair.
-
MIL@b has nourished extensive network of scientific national and international collaborators
